Try our mobile app

Published: 2021-04-26 09:30:31 ET
<<<  go to PFE company page
pfe-20210422
0000078003false00000780032021-04-222021-04-220000078003us-gaap:CommonStockMember2021-04-222021-04-220000078003pfe:NotesDue20220.250Member2021-04-222021-04-220000078003pfe:NotesDue20271.000Member2021-04-222021-04-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 22, 2021

PFIZER INC.
(Exact name of registrant as specified in its charter)

Delaware1-361913-5315170
(State or other(Commission File(I.R.S. Employer
jurisdiction ofNumber)Identification No.)
incorporation)  
235 East 42nd Street10017
New York, New York (Zip Code)
(Address of principal executive offices)

Registrant’s telephone number, including area code:
(212) 733-2323

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.05 par valuePFENew York Stock Exchange
0.250% Notes due 2022PFE22New York Stock Exchange
1.000% Notes due 2027PFE27New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐


Item 5.07   Submission of Matters to a Vote of Security Holders

(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 22, 2021.
(b) Shareholders voted on the matters set forth below.
1.  The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2021 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following votes:
Nominee
Votes For
 Votes Against
Abstentions
Broker non-vote
Ronald E. Blaylock3,552,128,58175,310,20517,769,916872,247,240
Albert Bourla3,403,798,711212,217,14429,192,847872,247,240
Susan Desmond-Hellmann3,602,587,18627,007,65515,613,861872,247,240
Joseph J. Echevarria3,067,343,922551,543,05226,321,728872,247,240
Scott Gottlieb3,604,408,88624,247,14716,552,669872,247,240
Helen H. Hobbs3,591,164,31138,498,00015,546,391872,247,240
Susan Hockfield3,606,052,11924,001,80915,154,774872,247,240
Dan R. Littman3,598,774,84828,603,95217,829,902872,247,240
Shantanu Narayen3,590,073,40138,138,23316,997,068872,247,240
Suzanne Nora Johnson3,477,324,059151,820,88016,063,763872,247,240
James Quincey3,588,511,16940,095,58016,601,953872,247,240
James C. Smith3,575,587,76453,048,89716,572,041872,247,240

2.  The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2021 fiscal year was approved based upon the following votes:
Votes for approval4,291,626,166
Votes against208,758,238
Abstentions17,071,538
Broker non-votesn/a
3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:
Votes for approval3,355,194,651
Votes against258,664,414
Abstentions31,349,637
Broker non-votes872,247,240

4. The shareholder proposal regarding independent chair policy was not approved based upon the following votes:
Votes for approval1,347,236,928
Votes against2,260,655,067
Abstentions37,316,707
Broker non-votes872,247,240


5. The shareholder proposal regarding political spending report was not approved based upon the following votes:
Votes for approval1,636,845,263
Votes against1,829,127,739
Abstentions179,235,700
Broker non-votes872,247,240
6. The shareholder proposal regarding report on access to COVID-19 products was not approved based upon the following votes:
Votes for approval1,011,019,874
Votes against2,562,817,160
Abstentions71,371,668
Broker non-votes872,247,240




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 PFIZER INC.
   
   
Dated: April 26, 2021By:/s/ Margaret M. Madden
  Margaret M. Madden
  Senior Vice President and Corporate Secretary
  Chief Governance Counsel